|
105 Companies |
|
193 Products |
|
193 Products |
|
133 Mechanisms of Action |
|
26 Trials |
|
4426 News |
|
| «12...1213141516171819202122...8990» |
- Enrollment change, Trial termination, Trial primary completion date: TRACER RGD-K5 Carotid Plaque Imaging Study (clinicaltrials.gov) - Jan 10, 2017
P2, N=3, Terminated, Sponsor: The Cleveland Clinic
N=15 --> 3 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Jun 2016; Investigator left instititution
- ticagrelor / Generic mfg., prasugrel / Generic mfg.
Trial completion: Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease (clinicaltrials.gov) - Jan 10, 2017
P4, N=22, Completed, Sponsor: University of Patras
N=15 --> 3 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Jun 2016; Investigator left instititution Recruiting --> Completed
- Neovasculgen (PI-VEGF165) / Human Stem Cells Institute
Trial completion, Phase classification, Trial primary completion date: NVG-LIGHT: Non-Interventional Post Marketing Surveillance Study of Neovasculgen (clinicaltrials.gov) - Jan 10, 2017
P4, N=210, Completed, Sponsor: Human Stem Cell Institute, Russia
Recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | Trial primary completion date: May 2015 --> Jan 2017
- Trial completion: Differential Effect of High (200?g/kg/Min) Adenosine Dose on Fractional Flow Reserve in Patients Presenting Variation of FFR ?0.05 During the Usual Dose of Adenosine Infusion (140?g/kg/Min). (clinicaltrials.gov) - Jan 10, 2017
P3, N=30, Completed, Sponsor: University of Patras
Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | Trial primary completion date: May 2015 --> Jan 2017 Recruiting --> Completed
- | ticagrelor / Generic mfg., clopidogrel / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: ALTIC: A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction (clinicaltrials.gov) - Jan 10, 2017
P4, N=20, Recruiting, Sponsor: University of Patras
Recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Mar 2016 --> Jan 2017 | Trial primary completion date: Dec 2016 --> Jan 2018
- Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion, Trial primary completion date: OFDI-DM: Optical Frequency Domain Imaging (OFDI) and Vascular Healing After Stent Placement (clinicaltrials.gov) - Jan 9, 2017
P=N/A, N=8, Completed, Sponsor: Emory University
Not yet recruiting --> Recruiting | Initiation date: Mar 2016 --> Jan 2017 | Trial primary completion date: Dec 2016 --> Jan 2018 Active, not recruiting --> Completed | Trial primary completion date: Jul 2016 --> Mar 2016
- Trial completion: Cook Micronized Small Intestinal Submucosa (SIS) for Critical Limb Ischemia (clinicaltrials.gov) - Jan 6, 2017
P=N/A, N=10, Completed, Sponsor: Cook
Active, not recruiting --> Completed | Trial primary completion date: Jul 2016 --> Mar 2016 Active, not recruiting --> Completed
- New trial: Soundbite Crossing System Peripheral First in Man (clinicaltrials.gov) - Jan 5, 2017
P=N/A, N=50, Recruiting, Sponsor: SoundBite Medical Solutions, Inc.
- New P2 trial: Angiosome Perfusion After Tibial Bypass (clinicaltrials.gov) - Jan 5, 2017
P2, N=40, Completed, Sponsor: University Hospital Erlangen
- atuliflapon (AZD-5718) / AstraZeneca
Enrollment open: A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet (clinicaltrials.gov) - Jan 5, 2017
P1, N=12, Recruiting, Sponsor: AstraZeneca
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion, Enrollment change, Trial primary completion date: HADIF: HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=13, Completed, Sponsor: Universita di Verona
Not yet recruiting --> Recruiting Recruiting --> Completed | N=132 --> 13 | Trial primary completion date: Jan 2017 --> Sep 2015
- Trial completion: SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=326, Completed, Sponsor: Rigshospitalet, Denmark
Recruiting --> Completed | N=132 --> 13 | Trial primary completion date: Jan 2017 --> Sep 2015 Recruiting --> Completed
- Trial completion, Trial primary completion date: IMPACT: Prevention Trial to Achieve Cardiovascular Targets (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=400, Completed, Sponsor: New York University School of Medicine
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jun 2017 --> May 2016
- Trial suspension, Surgery: Telomere Biology and AKI in Cardiac Surgery (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=1000, Suspended, Sponsor: Queen Mary University of London
Recruiting --> Completed | Trial primary completion date: Jun 2017 --> May 2016 Recruiting --> Suspended
- ticagrelor / Generic mfg., clopidogrel / Generic mfg.
Enrollment open, Trial primary completion date: PLATIDE-PCI: Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention (clinicaltrials.gov) - Jan 4, 2017
P4, N=40, Recruiting, Sponsor: Peking Union Medical College Hospital
Recruiting --> Suspended Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2017 --> Mar 2018
- Trial completion, Trial primary completion date, Heterogeneity: PROMETHE: Prognostic Value of Myocardial Perfusion Heterogeneity in Normal SPECT Studies (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=1119, Completed, Sponsor: University Hospital, Grenoble
Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2017 --> Mar 2018 Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Oct 2015
- ||| Trial completion, Machine learning: Machine leArning Based CT angiograpHy derIved FFR: a Multi-ceNtEr, Registry (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=352, Completed, Sponsor: Erasmus Medical Center
Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Oct 2015 Active, not recruiting --> Completed
- Enrollment closed, Trial primary completion date: VIDA Mobile Health Cardiovascular Prevention Program (clinicaltrials.gov) - Dec 30, 2016
P=N/A, N=34, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Mar 2017
- New trial: SHIP-CS: The Sakakibara Health Integrative Profile Cohort Study (clinicaltrials.gov) - Dec 28, 2016
P=N/A, N=32095, Completed, Sponsor: Sakakibara Heart Institute
- || New P3 trial: Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study (clinicaltrials.gov) - Dec 28, 2016
P3, N=400, Recruiting, Sponsor: CathWorks Ltd.
- | New P2a trial: Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease (clinicaltrials.gov) - Dec 28, 2016
P2a, N=24, Not yet recruiting, Sponsor: MedImmune LLC
- ||||| Enrollment closed: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME) (clinicaltrials.gov) - Dec 28, 2016
P3, N=60, Active, not recruiting, Sponsor: Boston Scientific Corporation
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Mar 2017 Recruiting --> Active, not recruiting
- Enrollment change: ULTRA-FAST: Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment (clinicaltrials.gov) - Dec 27, 2016
P=N/A, N=860, Recruiting, Sponsor: Kenichiro Yamagata
Recruiting --> Active, not recruiting N=300 --> 860
- New trial: PRELUDE: PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE (clinicaltrials.gov) - Dec 22, 2016
P=N/A, N=30, Not yet recruiting, Sponsor: Cagent Vascular LLC
- New trial: The Study of CCTM and Common Diseases (clinicaltrials.gov) - Dec 21, 2016
P=N/A, N=3748, Completed, Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine
- Enrollment open: Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=500, Recruiting, Sponsor: Hospital Universitari Vall d'Hebron Research Institute
N=300 --> 860 Not yet recruiting --> Recruiting
- ticagrelor / Generic mfg., clopidogrel / Generic mfg.
Enrollment change, Trial withdrawal: Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study (clinicaltrials.gov) - Dec 20, 2016
P4, N=0, Withdrawn, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting N=47 --> 0 | Terminated --> Withdrawn
- aspirin / Generic mfg.
New trial: FirstAMOS: First Approach for Aspirin Misuse Objective Screening (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=400, Enrolling by invitation, Sponsor: University Hospital, Angers
- Trial termination, Trial primary completion date: WELCH: Walking Impairment Questionnaire in PAD (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=340, Terminated, Sponsor: University Hospital, Angers
N=47 --> 0 | Terminated --> Withdrawn Recruiting --> Terminated | Trial primary completion date: Nov 2011 --> May 2012; recruitment problem due to administrative process being too long
- | sirolimus / Generic mfg.
Trial completion: DESSOLVE-I: First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (clinicaltrials.gov) - Dec 19, 2016
P2, N=30, Completed, Sponsor: Micell Technologies
Recruiting --> Terminated | Trial primary completion date: Nov 2011 --> May 2012; recruitment problem due to administrative process being too long Active, not recruiting --> Completed
- Trial primary completion date: Stethosport: Evaluation of Patients With Suspected Endofibrosis (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=100, Recruiting, Sponsor: University Hospital, Angers
Active, not recruiting --> Completed Trial primary completion date: Jul 2017 --> Jul 2018
- Trial completion, Trial primary completion date: SARTORIUS: Tissue Lesions in Exercise Related Ischemia (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=36, Completed, Sponsor: University Hospital, Angers
Trial primary completion date: Jul 2017 --> Jul 2018 Not yet recruiting --> Completed | Trial primary completion date: Oct 2017 --> Nov 2016
- Trial completion, Trial primary completion date: Claudication Evaluation During Rowing ExerciseS (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=6, Completed, Sponsor: University Hospital, Angers
Not yet recruiting --> Completed | Trial primary completion date: Oct 2017 --> Nov 2016 Not yet recruiting --> Completed | Trial primary completion date: Jul 2016 --> Nov 2016
- New trial: PROTECTION-VI: Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017 (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=2000, Not yet recruiting, Sponsor: Klinikum der Universitaet Muenchen
- Trial completion, Enrollment change, HEOR: Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD) (clinicaltrials.gov) - Dec 16, 2016
P=N/A, N=323, Completed, Sponsor: University of Washington
Not yet recruiting --> Completed | Trial primary completion date: Jul 2016 --> Nov 2016 Active, not recruiting --> Completed | N=1100 --> 323
- ||| Enrollment open: Prepare II: User Evaluation Study of SyncVision System With Software v4.X (clinicaltrials.gov) - Dec 15, 2016
P=N/A, N=200, Recruiting, Sponsor: Volcano Corporation
Active, not recruiting --> Completed | N=1100 --> 323 Not yet recruiting --> Recruiting
- New trial: The Copenhagen City Heart Study (clinicaltrials.gov) - Dec 15, 2016
P=N/A, N=23891, Completed, Sponsor: Bispebjerg Hospital
- | Trial completion: An Investigation to Evaluate an Over-The-Wire FFR Infusion Microcatheter (HYPEREM (clinicaltrials.gov) - Dec 14, 2016
P=N/A, N=41, Completed, Sponsor: Diasolve Ltd
Not yet recruiting --> Recruiting Recruiting --> Completed
- New trial: Oxygen Concentration and Recovery After Carotid Endarterectomy (clinicaltrials.gov) - Dec 14, 2016
P=N/A, N=100, Recruiting, Sponsor: Osijek University Hospital
- || Trial primary completion date: DXR Stent(Previous Cilotax) Implantation Registry (clinicaltrials.gov) - Dec 13, 2016
P=N/A, N=1000, Recruiting, Sponsor: Seung-Jung Park
Recruiting --> Completed Trial primary completion date: Jun 2016 --> Feb 2018
- Xience (everolimus-eluting stent) / Abbott
Trial completion, Trial primary completion date: Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus (clinicaltrials.gov) - Dec 13, 2016
P4, N=300, Completed, Sponsor: Seung-Jung Park
Trial primary completion date: Jun 2016 --> Feb 2018 Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Aug 2015
- Enrollment change, Trial primary completion date, Surgery: Circulatory Oscillations in Post Cardiac Surgery Patients (clinicaltrials.gov) - Dec 13, 2016
P=N/A, N=20, Recruiting, Sponsor: St. Olavs Hospital
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Aug 2015 N=10 --> 20 | Trial primary completion date: Oct 2016 --> Dec 2017
- New trial: Cardiovascular Risk Evaluation in Psoriasis Treated With Photochemotherapy (clinicaltrials.gov) - Dec 13, 2016
P=N/A, N=65, Completed, Sponsor: Cairo University
- Enrollment closed: Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction (clinicaltrials.gov) - Dec 12, 2016
P=N/A, N=151, Active, not recruiting, Sponsor: Kamil Novob
N=10 --> 20 | Trial primary completion date: Oct 2016 --> Dec 2017 Recruiting --> Active, not recruiting
- ||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment closed, Trial primary completion date: LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) (clinicaltrials.gov) - Dec 9, 2016
P4, N=400, Active, not recruiting, Sponsor: Seung-Jung Park
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2017
- ||| Absorb (everolimus-eluting bioresorbable vascular scaffold) / Abbott
Trial completion: ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (clinicaltrials.gov) - Dec 9, 2016
P=N/A, N=183, Completed, Sponsor: Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2017 Active, not recruiting --> Completed
- NN1213 / Novo Nordisk
Trial completion, Trial primary completion date: The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries (clinicaltrials.gov) - Dec 9, 2016
P=N/A, N=200, Completed, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2010 --> Apr 2007
- Trial completion, Enrollment change, Trial primary completion date: Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit (clinicaltrials.gov) - Dec 9, 2016
P4, N=210, Completed, Sponsor: University of Utah
Active, not recruiting --> Completed | Trial primary completion date: Jul 2010 --> Apr 2007 Recruiting --> Completed | N=150 --> 210 | Trial primary completion date: Apr 2015 --> Nov 2016
- Trial primary completion date: Cardiovascular Disease Study (clinicaltrials.gov) - Dec 8, 2016
P=N/A, N=200, Recruiting, Sponsor: VA Office of Research and Development
Recruiting --> Completed | N=150 --> 210 | Trial primary completion date: Apr 2015 --> Nov 2016 Trial primary completion date: Dec 2019 --> Dec 2021
- Enrollment closed: RIPC-PVD: Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial (clinicaltrials.gov) - Dec 8, 2016
P1, N=40, Active, not recruiting, Sponsor: National University of Ireland, Galway, Ireland
Trial primary completion date: Dec 2019 --> Dec 2021 Recruiting --> Active, not recruiting